Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA

NCT07224789 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-11-19

No results posted yet for this study

Summary

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

cf-circRNA assay

Circular RNA detection in plasma or serum by RT-qPCR

Sponsors & Collaborators

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Ajay Goel, PhD · City of Hope Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2026-06-18
Completion
2026-06-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07224789 on ClinicalTrials.gov